Geode Capital Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.9M | Sell |
1,722,405
-26,789
| -2% | -$1.43M | 0.01% | 1076 |
|
|
2025
Q1 | $70.8M | Buy |
1,749,194
+189,563
| +12% | +$7.68M | 0.01% | 1170 |
|
|
2024
Q4 | $43.4M | Sell |
1,559,631
-11,381
| -0.7% | -$317K | ﹤0.01% | 1512 |
|
|
2024
Q3 | $45.1M | Sell |
1,571,012
-48,027
| -3% | -$1.38M | ﹤0.01% | 1488 |
|
|
2024
Q2 | $38M | Buy |
1,619,039
+199,732
| +14% | +$4.69M | ﹤0.01% | 1540 |
|
|
2024
Q1 | $35.9M | Buy |
1,419,307
+253,062
| +22% | +$6.39M | ﹤0.01% | 1578 |
|
|
2023
Q4 | $27.2M | Buy |
1,166,245
+62,939
| +6% | +$1.47M | ﹤0.01% | 1726 |
|
|
2023
Q3 | $55.8M | Buy |
1,103,306
+278,599
| +34% | +$14.1M | 0.01% | 1157 |
|
|
2023
Q2 | $38.5M | Buy |
824,707
+158,780
| +24% | +$7.41M | ﹤0.01% | 1422 |
|
|
2023
Q1 | $25.5M | Buy |
665,927
+32,547
| +5% | +$1.25M | ﹤0.01% | 1641 |
|
|
2022
Q4 | $34.7M | Buy |
633,380
+110,091
| +21% | +$6.03M | ﹤0.01% | 1397 |
|
|
2022
Q3 | $17.8M | Buy |
523,289
+55,304
| +12% | +$1.88M | ﹤0.01% | 1818 |
|
|
2022
Q2 | $4.42M | Buy |
467,985
+24,512
| +6% | +$232K | ﹤0.01% | 2767 |
|
|
2022
Q1 | $6.29M | Buy |
443,473
+26,792
| +6% | +$380K | ﹤0.01% | 2660 |
|
|
2021
Q4 | $8.81M | Buy |
416,681
+38,988
| +10% | +$825K | ﹤0.01% | 2538 |
|
|
2021
Q3 | $8.44M | Buy |
377,693
+15,115
| +4% | +$338K | ﹤0.01% | 2586 |
|
|
2021
Q2 | $9M | Buy |
362,578
+98,095
| +37% | +$2.43M | ﹤0.01% | 2529 |
|
|
2021
Q1 | $7.67M | Buy |
264,483
+22,821
| +9% | +$662K | ﹤0.01% | 2544 |
|
|
2020
Q4 | $6.23M | Buy |
241,662
+7,792
| +3% | +$201K | ﹤0.01% | 2480 |
|
|
2020
Q3 | $7.2M | Buy |
233,870
+93,903
| +67% | +$2.89M | ﹤0.01% | 2169 |
|
|
2020
Q2 | $3.49M | Buy |
139,967
+26,060
| +23% | +$649K | ﹤0.01% | 2527 |
|
|
2020
Q1 | $2.41M | Buy |
113,907
+34,663
| +44% | +$735K | ﹤0.01% | 2577 |
|
|
2019
Q4 | $1.76M | Buy |
79,244
+4,713
| +6% | +$105K | ﹤0.01% | 3068 |
|
|
2019
Q3 | $1.7M | Buy |
+74,531
| New | +$1.7M | ﹤0.01% | 3028 |
|